Article: Neurocrine Biosciences Presents Six Indiplon Studies at the Associated Professional Sleep Societies (APSS) Meeting.

Results Demonstrate Indiplon Significantly Improves Sleep Initiation and Sleep Maintenance

Neurocrine Biosciences, Inc. announced today that six studies from Phase I, II and III clinical trials with both formulations of indiplon will be presented at the Associated Professional Sleep Societies (APSS) Meeting, June 5-10, 2004 in Philadelphia, PA. The studies demonstrate that two formulations of indiplon, an immediate release capsule and a modified release tablet, can help patients with insomnia fall asleep faster and stay asleep longer without experiencing next-day residual effects.

"These data being presented further reinforce the robustness of the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!